alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,001–7,025 of 7,816 matching trials · page 281 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics
NCT01194713
Sleep deprivation
Runs in: Netherlands · 1 site 		NA
other		 COMPLETED 26 University Medical Center Nijmegen
OTHER		 2014-05-13
Cilostazol Augmentation Study in Dementia
NCT01409564
Cilostazol; Placebo
Runs in: South Korea · 1 site 		PHASE4
other		 COMPLETED 46 Seoul National University Hospital
OTHER		 2014-05-13
Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease
NCT01254773
Experimental Bapineuzumab
Runs in: United States · 28 sites 		PHASE2
anti-amyloid-antibody		 COMPLETED 146 JANSSEN Alzheimer Immunotherapy Research & Development, LLC
INDUSTRY		 2014-05-09
The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule
NCT01978730
high dose group of SaiLuoTong capsule; low dose group of SaiLuoTong...
Runs in: China · 16 sites 		PHASE2
other		 UNKNOWN 372 Shineway Pharmaceutical Co.,Ltd
INDUSTRY		 2014-05-08
Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease
NCT00480701
[123I]-IBVM
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 26 Institute for Neurodegenerative Disorders
OTHER		 2014-05-07
Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease
NCT00812565
Placebo; octagam 10%
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 58 Octapharma
INDUSTRY		 2014-05-05
The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease
NCT01181921
Galantamine
Runs in: Spain · 1 site 		PHASE4
symptomatic-cholinergic		 TERMINATED 1 Janssen-Cilag, S.A.
INDUSTRY		 2014-05-01
ThinkingFit: Combined Physical, Cognitive and Social Treatment in Mild Cognitive Impairment (MCI)
NCT01603862
ThinkingFit programme
Runs in: United Kingdom · 1 site 		NA
other		 COMPLETED 128 Dr Thomas Dannhauser
OTHER_GOV		 2014-04-28
Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
NCT01073228
EVP-6124; Placebo
Runs in: Romania; Russia; Serbia; Ukraine; United States · 54 sites 		PHASE2
other		 COMPLETED 409 FORUM Pharmaceuticals Inc
INDUSTRY		 2014-04-25
Clinical Trial of CNS-targeted HAART (CIT2)
NCT00624195
FDA Approved Antiretroviral Therapy (see list below)
Runs in: United States · 5 sites 		PHASE2|PHASE3
other		 COMPLETED 59 University of California, San Diego
OTHER		 2014-04-23
Safety and Tolerability of Etanercept in Alzheimer's Disease
NCT01068353
Etanercept; Placebo
Runs in: United Kingdom · 1 site 		PHASE2
other		 COMPLETED 41 University of Southampton
OTHER		 2014-04-23
Brazil Nuts Effects on Selenium Status and Cognitive Performance
NCT02121457
Brazil nut; selenium
Runs in: Brazil · 1 site 		NA
other		 COMPLETED 31 University of Sao Paulo
OTHER		 2014-04-23
Effects of Exercise Training in Patients With Mild Cognitive Impairment
NCT01724151
Runs in: Taiwan · 1 site 		NA
other		 COMPLETED 60 National Taiwan University Hospital
OTHER		 2014-04-22
Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias
NCT01730430
Runs in: United States · 1 site 		NA
other		 COMPLETED 40 Duke University
OTHER		 2014-04-22
Effect of NeuroAD on Alzheimer Patients
NCT01825317
NeuroAD; Sham device
Runs in: South Korea · 1 site 		NA
other		 COMPLETED 32 Neuronix Ltd
INDUSTRY		 2014-04-21
Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease
NCT02119546
Aerobic exercise; Stretch exercise
Runs in: Taiwan · 1 site 		NA
other		 COMPLETED 19 National Taiwan University Hospital
OTHER		 2014-04-21
An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease
NCT00814801
Placebo; Galantamine 16 mg/day; Galantamine 24 mg/day
Runs in: Japan · 1 site 		PHASE3
symptomatic-cholinergic		 COMPLETED 580 Janssen Pharmaceutical K.K.
INDUSTRY		 2014-04-17
PRISM Registry: Pseudobulbar Affect Registry Series
NCT01366027
Runs in: United States · 1 site 		NA
other		 COMPLETED 5,290 Avanir Pharmaceuticals
INDUSTRY		 2014-04-16
A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
NCT02005991
PF-05212377; PF-05212377; PF-05212377
Runs in: United States · 3 sites 		PHASE1
other		 COMPLETED 4 Pfizer
INDUSTRY		 2014-04-16
Brain Plasticity Following Aerobic Exercise in Patient With Mild Cognitive Impairment: Neuroimaging Study
NCT02114580
physical training
Runs in: Israel · 1 site 		NA
other		 UNKNOWN 40 Tel-Aviv Sourasky Medical Center
OTHER_GOV		 2014-04-15
The Relationship Between Metamemory and Memory in Old Age
NCT02113345
Metamemory Cognitive Intervention
Runs in: Hong Kong · 1 site 		NA
other		 UNKNOWN 60 The University of Hong Kong
OTHER		 2014-04-14
Prospective Memory Imaging
NCT01638884
Memory assessment; Structural MRI; Functional MRI; Virtual reality ...
Runs in: France · 3 sites 		NA
other		 UNKNOWN 118 University Hospital, Caen
OTHER		 2014-04-09
Imaging of New Learning in Severe Alzheimer's Disease Patients
NCT01839422
Memory assessment; Brain imaging examination MRI
Runs in: France · 1 site 		NA
other		 UNKNOWN 60 University Hospital, Caen
OTHER		 2014-04-09
Yogic Breathing Changes Salivary Components
NCT02108769
Yogic Breathing; Attention Control
Runs in: United States · 1 site 		NA
other		 COMPLETED 20 Medical University of South Carolina
OTHER		 2014-04-09
Effect of Deksmedetomidine and Remifentanil in Extubation Agitation
NCT02104297
deksmedetomidine; Remifentanil; Saline
Runs in: Turkey (Türkiye) · 1 site 		PHASE4
other		 UNKNOWN 90 Diskapi Yildirim Beyazit Education and Research Hospital
OTHER_GOV		 2014-04-04

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →